Start free trial
Markets US Stocks Health Technology Pharmaceuticals: Generic

Abeona Therapeutics Inc

ABEO NASDAQ
ABEO
Abeona Therapeutics Inc NASDAQ
See more on the world's #1 chartsSee more on the world's #1 charts
 
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
See more on the world's #1 chartsSee more on the world's #1 charts
Overview
Ideas Financials Technicals

ABEO Stock Chart

Ideas

Videos only
ABEO buy if 1,70
ABEO
, 1D
Long
ABEO: ABEO buy if 1,70

buy it if 1,70, if it could be stop-loss buy again!

ABEO
ABEO
, 60
Long
ABEO: ABEO

Looking at the gap around $1.10 for a possible position. For my educational purpose, not to be used as financial advice.

mid term +25,000% (love this one)
ABEO
, 1M
ABEO: mid term +25,000% (love this one)

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases.

its to buy
ABEO
, 1D
Long
ABEO: its to buy

beautiful return back to track for long its to call

ABEO support lines
ABEO
, 240
ABEO: ABEO support lines

support resistance

ABEO, at support with really Nice divergence on the 4 hour.
ABEO
, 240
Long
ABEO: ABEO, at support with really Nice divergence on the 4 hour.

At support with really Nice divergence on the 4 hour. #NFA

ABEO for the people
ABEO
, 1D
ABEO: ABEO for the people

Back in let's see how it goes. Long term higher risk hold Not investment advice just my ideas www.abeonatherapeutics.com Cheers

Posibility
ABEO
, 1W
Long
ABEO: Posibility

Very annoyed with this stock's performance, but looking at the big picture...

ABEO NASDAQ
ABEO
, 1D
Long
ABEO: ABEO NASDAQ

stop: 1.96

Bullish Bat
ABEO
, 60
Long
ABEO: Bullish Bat

ABEO - H chart formed a bullish hrmonic pattern called BAT so BUY around 2.30 to 2.10 T1 2.75 T2 3.13 SL closing below 1.90

follow-up after seeing the chart from @PlanTradePlanMM
ABEO
, 1W
ABEO: follow-up after seeing the chart from @PlanTradePlanMM

According to its website, it is a fully-integrated gene and cell therapy company at the forefront of the rapidly-advancing field of genetic medicine. Our expertise across R&D, manufacture, and discovery of novel gene and cell therapies has us uniquely positioned to bring new medicines to patients in need.

ABEO Long
ABEO
, 1D
Long
ABEO: ABEO Long

One swing crossed SMA50 and SMA200 trendline break and re-test Entry 2.75 no Stop Target 5 I am not a PRO trader. I trade option to test my trading plan with small cost. The max Risk of each plan is less than 1% of my account. If you like this idea, please use SIM/Demo account to try it.

ABEO W1: BEST Level to BUY/HOLD 200%+ gains(SL/TP)(STOCKS)
ABEO
, 1W
Long
ABEO: ABEO W1: BEST Level to BUY/HOLD 200%+ gains(SL/TP)(STOCKS)

Why get subbed to me on Tradingview? -TOP author on TradingView -15+ years experience in markets -Professional chart break downs -Supply/Demand Zones -TD9 counts / combo review -Key S/R levels -No junk on my charts -Frequent updates -Covering FX/crypto/US stocks -24/7 uptime so constant updates ABEO W1: BEST Level to BUY/HOLD 200%+...

ABEO took profit at 2.66
ABEO
, 1D
Long
ABEO: ABEO took profit at 2.66

Good luck to those holding

ABEO Long Idea
ABEO
, 1W
Long
ABEO: ABEO Long Idea

This is my idea about this stock

ABEO 12% in 2 days
ABEO
, 1D
Long
ABEO: ABEO 12% in 2 days

2.62 Pre market price, do you think we can take profit on monday?

ABEO bought at 2.34
ABEO
, 1D
Long
ABEO: ABEO bought at 2.34

We have bought in 4 stocks yesterday

Abeona Theraputic Inc buy opportunity
ABEO
, 1M
Long
ABEO: Abeona Theraputic Inc buy opportunity

Buy in the range of 1,46-1,56 with a stop loss of 0,99 and the targets as resistance line to scale out of your position.

Show more ideas

Technicals

Financials

Valuation
Enterprise Value/EBITDA, TTM —
Enterprise Value, FQ —
Market Cap — Basic —
Number of Employees —
Number of Shareholders —
Price/Earnings, TTM —
Price/Revenue, TTM —
Price/Book Ratio, FY —
Price/Sales Ratio, FY —
Balance Sheet
Current Ratio, FQ —
Debt to Equity, FQ —
Net Debt, FQ —
Quick Ratio, FQ —
Total Assets, FQ —
Total Debt, FQ —
Operating Metrics
Return on Assets, TTM —
Return on Equity, TTM —
Return on Invested Capital, TTM —
Revenue per Employee, TTM —
Price History
Average Volume (10 day) —
Beta - 1 Year —
Price - 52 Week High —
Price - 52 Week Low —
Dividends
Dividends Paid, FY —
Dividends per Share, FY —
Expected Annual Dividends —
Dividends Yield —
Margins
Net Margin, TTM —
Gross Margin, TTM —
Operating Margin, TTM —
Pretax Margin, TTM —
Income Statement
Basic EPS, Net Income —
Earnings per Share, Basic, TTM —
EBITDA, TTM —
Gross Profit, FY —
Last Annual EPS —
Last Annual Revenue, FY —
Net Income, FY —
Total Revenue, FY —
Free Cash Flow, TTM —
More financials

Profile

Sector: Health Technology
Industry: Pharmaceuticals: Generic
Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB); ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in New York, NY.

Breaking news